References
- Schön MP, Boehncke WH. Psoriasis. N Engl J Med. 2005; 352: 1899–912
- Iizuka H, Takahashi H, Yamamoto AI. Pathophysiology of generalized pustular psoriasis. Arch Dermatol Res. 2003; 295: S55–9
- Welsch MJ. Acute pustular psoriasis complicated by leucocytoclastic vasculitis. J Drugs Dermatol. 2003; 2: 193–7
- Hemlock C, Rosenthal JS, Winston A. Fluoxetine induced psoriasis. Ann Pharmacother. 1992; 26: 211–12
- Osborne SF, Stafford L, Orr KGD. Paroxetine-associated psoriasis [letter]. Am J Psychiatry. 2002; 159: 2113
- Naranjo CA, Busto U, Sellers EM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30: 239–45
- Gupta MA, Gupta AK. The use of antidepressant drugs in dermatology. J Eur Acad Dermatol. 2001; 15: 512–18
- Stefulj J, Jernej B, Cicin-Sain L, Rinner I. Schauenstein KmRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav Immun. 2000; 14: 219–24
- Pellegrino TC, Bayer BM. Role of central 5-HT2 receptors in fluoxetine-induced decreases in T lymphocyte activity. Brain Behav Immun. 2002; 16: 87–103
- Mossner R, Lesch KP. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun. 1998; 12: 249–71
- Huang J, Li G, Xiang J. Immunohistochemical study of serotonin in lesions of psoriasis. Int J Dermatol. 2004; 43: 408–11
- Abdouh M, Storring JM, Riad M. Transcriptional mechanisms for induction of 5-HT1A receptor mRNA and protein in activated B and T lymphocytes. J Biol Chem. 2001; 276: 4382–8
- Maurer M, Opitz M, Henz BM. The mast cell products histamine and serotonin stimulate and TNF-alpha inhibits the proliferation of murine epidermal keratinocytes in situ. J Dermatol Sci. 1997; 16: 79–84
- Young MR, Matthews JP. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology. 1995; 84: 148–52
- Laberge S, Cruikshank WW, Beer DJ. Secretion of IL-16 from serotonin stimulated CD8+ T cells in vitro. J Immunol. 1996; 156: 310–15
- Thorslund K, Nordlind K. Serotonergic drugs – A possible role in the treatment of psoriasis?. Drug News Perspect. 2007; 20: 521–5
- Nordlind K, Thorslund K, Lonne-Rahm S, Mohabbati S, Berki T, Morales M, et al. Expression of serotonergic receptors in psoriatic skin. Arch Dermatol Res. 2006; 298: 99–106
- RubioF, Jensen BK, Henderson L. Disposition of [14C] acitretin in humans following oral administration. Drug Metab Dispos. 1994; 22: 211–15
- Koo JYM, Lee CS, Maloney JE. Cyc A and related drugs. In: Wolverton SE, editor. Comprehensive dermatologic drug therapy. WB Saunders Company: Philadelphia; 2001. p. 205–29.
- Richelson E. Pharmacokinetic drug interactions of new antidepressants: A review of the effects on the metabolism of other drugs. Mayo Clin Proc. 1997; 72: 835–47
- Greenblatt DJ, von Moltke LL, Harmatz JS. Drug interactions with newer antidepressants: Role of human cytochromes P450. J Clin Psychiatry. 1998; 59((suppl 15)):19–27